Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
NATERA INC via NATERA INC
2026 · third_quarter · Q3
Advocacy on importance of FDA's oversight of Laboratory Developed Tests and impact on industry and patients. Advocacy on CMS administrative procedures regarding Date of Service (DOS) for Laboratory testing for patients.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATERA INC via NATERA INC
2026 · second_quarter · Q2
Source: Senate LDA
Advocacy on importance of FDA's oversight of Laboratory Developed Tests and impact on industry and patients. Advocacy on CMS administrative procedures regarding Date of Service (DOS) for Laboratory testing for patients.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATERA INC via NATERA INC
2026 · first_quarter · Q1
Advocacy on importance of FDA's oversight of Laboratory Developed Tests and impact on industry and patients. Advocacy on CMS administrative procedures regarding Date of Service (DOS) for Laboratory testing for patients.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATERA INC via NATERA INC
2025 · fourth_quarter · Q4
Advocacy on importance of FDA's oversight of Laboratory Developed Tests and impact on industry and patients. Advocacy on CMS administrative procedures regarding Date of Service (DOS) for Laboratory testing for patients.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATERA INC via NATERA INC
2025 · third_quarter · Q3
Advocacy on importance of FDA's oversight of Laboratory Developed Tests and impact on industry and patients. Advocacy on CMS administrative procedures regarding Date of Service (DOS) for Laboratory testing for patients.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATERA INC via NATERA INC
2025 · second_quarter · Q2
Advocacy on importance of FDA's oversight of Laboratory Developed Tests and impact on industry and patients. Advocacy on CMS administrative procedures regarding Date of Service (DOS) for Laboratory testing for patients.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATERA INC via NATERA INC
2025 · first_quarter · Q1
Advocacy on importance of FDA's oversight of Laboratory Developed Tests and impact on industry and patients. Advocacy on CMS administrative procedures regarding Date of Service (DOS) for Laboratory testing for patients.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATERA INC via NATERA INC
2025 · first_quarter · RR
Any federal legislation or regulations in regard to health care testing and diagnostics.